POTSDAM, GERMANY -- (Marketwire) -- 10/26/10 -- Signature Diagnostics AG announced today that the company was selected to present its newest blood-based products for colorectal cancer (CRC) screening -- Detector C and Detector C/Plus -- at the 18th United European Gastrointestinal Week (UEGW) Congress in Barcelona on October 22-26, 2010. The paper, "Early Detection of Colorectal Cancer Based on RNA Measurements in Blood," will be presented by the company's CEO, André Rosenthal, Ph.D, at the session "Colorectal Cancer Screening: New Strategies" on Wednesday, October 26, 2010 (Hall 14, 8:30-10:30am). Both Detector C and Detector C/Plus are extremely accurate and safe with a validated sensitivity of 90 percent and a validated specificity
More...
More...